×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

. (WCRX)

$22.93 - (-)

Market Cap: -

As of 11/14/13 12:00 AM EST. Market closed.

(WCRX)

. (WCRX)

$22.93
- (-)

Market Cap: -

As of 11/14/13 12:00 AM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$22.93
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$22.93
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Halstead MichaelSenior V.P., Corp. DevelopmentJul 01, 2013 Sale$19.883667,27651,840Jul 02, 2013, 05:43 PM
Sullivan Ryan TVP, General Counsel & Secr.Jul 01, 2013 Sale$19.881693,36026,460Jul 02, 2013, 05:42 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Apr 01, 2013 Sale$13.417039,428144,838Apr 01, 2013, 04:39 PM
CONNAUGHTON JOHNDirectorMar 04, 2013 Sale$13.4710,590,608142,655,4930Mar 06, 2013, 05:12 PM
Ellman HermanSenior V.P., Clinical Devel.Mar 01, 2013 Sale$13.381,66622,293181,223Mar 04, 2013, 04:04 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 28, 2013 Sale$13.4615,869213,655145,541Mar 01, 2013, 04:19 PM
Rodriguez Rama FranciscoSenior V.P., Tech. OperationsFeb 28, 2013 Sale$13.4682011,04030,529Mar 01, 2013, 04:13 PM
Gilligan Claire ASenior V.P., QualityFeb 28, 2013 Sale$13.462,35431,69477,632Mar 01, 2013, 04:13 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 28, 2013 Sale$13.461,32417,826204,826Mar 01, 2013, 04:12 PM
Fenton AndrewSenior V.P., CIOFeb 28, 2013 Sale$13.461,39018,715108,310Mar 01, 2013, 04:11 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 28, 2013 Sale$13.461,72823,26599,689Mar 01, 2013, 04:10 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 28, 2013 Sale$13.461,74723,52152,206Mar 01, 2013, 04:10 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 28, 2013 Sale$13.461,72823,26556,546Mar 01, 2013, 04:09 PM
Herendeen PaulExec. V.P. and CFOFeb 28, 2013 Sale$13.464,67462,929132,620Mar 01, 2013, 04:08 PM
Boissonneault Roger MCEO & PresidentFeb 28, 2013 Sale$13.4618,730252,1752,312,618Mar 01, 2013, 04:07 PM
Fenton AndrewSenior V.P., CIOFeb 19, 2013 Sale$14.534196,087109,700Feb 21, 2013, 04:12 PM
Ellman HermanSenior V.P., Clinical Devel.Feb 19, 2013 Sale$14.5369110,039182,889Feb 21, 2013, 04:11 PM
Gilligan Claire ASenior V.P., QualityFeb 19, 2013 Sale$14.531,04515,18179,986Feb 21, 2013, 04:11 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 19, 2013 Sale$14.535538,034206,150Feb 21, 2013, 04:10 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 19, 2013 Sale$14.5376711,143101,417Feb 21, 2013, 04:09 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 19, 2013 Sale$14.532,56237,220129,673Feb 21, 2013, 04:07 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 19, 2013 Sale$14.5376711,14358,274Feb 21, 2013, 04:06 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 19, 2013 Sale$14.534196,08753,953Feb 21, 2013, 04:05 PM
Herendeen PaulExec. V.P. and CFOFeb 19, 2013 Sale$14.531,96928,605137,294Feb 21, 2013, 04:04 PM
Boissonneault Roger MCEO & PresidentFeb 19, 2013 Sale$14.537,928115,1762,331,348Feb 21, 2013, 04:03 PM
Fenton AndrewSenior V.P., CIOFeb 01, 2013 Sale$14.1899614,12194,649Feb 04, 2013, 04:12 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 01, 2013 Sale$14.1880811,456191,233Feb 04, 2013, 04:11 PM
Ellman HermanSenior V.P., Clinical Devel.Feb 01, 2013 Sale$14.181,01014,320168,110Feb 04, 2013, 04:11 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 01, 2013 Sale$14.1899814,15038,902Feb 04, 2013, 04:10 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 01, 2013 Sale$14.181,01014,32086,714Feb 04, 2013, 04:10 PM
Gilligan Claire ASenior V.P., QualityFeb 01, 2013 Sale$14.181,37719,52365,561Feb 04, 2013, 04:09 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 01, 2013 Sale$14.1899814,15043,571Feb 04, 2013, 04:08 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 01, 2013 Sale$14.1813,790195,517132,235Feb 04, 2013, 04:07 PM
Herendeen PaulExec. V.P. and CFOFeb 01, 2013 Sale$14.182,84040,266101,543Feb 04, 2013, 04:03 PM
Boissonneault Roger MCEO & PresidentFeb 01, 2013 Sale$14.189,125129,3762,222,156Feb 04, 2013, 04:02 PM
Cross Leland HSenior V.P., Tech. OperationsJan 30, 2013 Sale$13.384656,224192,041Jan 31, 2013, 04:48 PM
Gilligan Claire ASenior V.P., QualityJan 30, 2013 Sale$13.384896,54566,938Jan 31, 2013, 04:48 PM
Fenton AndrewSenior V.P., CIOJan 30, 2013 Sale$13.383514,69895,645Jan 31, 2013, 04:47 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 30, 2013 Sale$13.385867,843169,120Jan 31, 2013, 04:47 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 30, 2013 Sale$13.385917,91087,724Jan 31, 2013, 04:46 PM
Fuhrmann RochelleSenior V.P., FinanceJan 30, 2013 Sale$13.382823,77444,569Jan 31, 2013, 04:45 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 30, 2013 Sale$13.383204,28339,900Jan 31, 2013, 04:45 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Jan 30, 2013 Sale$14.282,21531,621146,333Jan 31, 2013, 04:44 PM
Herendeen PaulExec. V.P. and CFOJan 30, 2013 Sale$13.382,20829,552104,383Jan 31, 2013, 04:43 PM
Boissonneault Roger MCEO & PresidentJan 30, 2013 Sale$13.388,470113,3632,231,281Jan 31, 2013, 04:43 PM
Fenton AndrewSenior V.P., CIOJan 22, 2013 Sale$13.506218,38395,996Jan 23, 2013, 04:13 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 22, 2013 Sale$13.501,16615,741169,706Jan 23, 2013, 04:12 PM
Gilligan Claire ASenior V.P., QualityJan 22, 2013 Sale$13.5094912,81167,427Jan 23, 2013, 04:11 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 22, 2013 Sale$13.501,22216,49788,315Jan 23, 2013, 04:10 PM
Cross Leland HSenior V.P., Tech. OperationsJan 22, 2013 Sale$13.5083911,326192,506Jan 23, 2013, 04:10 PM
Fuhrmann RochelleSenior V.P., FinanceJan 22, 2013 Sale$13.504886,58844,851Jan 23, 2013, 04:09 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 22, 2013 Sale$13.504886,58840,220Jan 23, 2013, 04:08 PM
Herendeen PaulExec. V.P. and CFOJan 22, 2013 Sale$13.504,30558,117106,591Jan 23, 2013, 04:07 PM
Boissonneault Roger MCEO & PresidentJan 22, 2013 Sale$13.5013,924187,9732,239,751Jan 23, 2013, 04:06 PM
Murray Stephen PDirectorNov 28, 2012 Sale$11.416,491,61874,069,3600Nov 30, 2012, 03:11 PM
Murray Stephen PDirectorNov 20, 2012 Sale$11.665,000,00058,299,9996,491,618Nov 20, 2012, 10:47 AM
Gilligan Claire ASenior V.P., QualityOct 01, 2012 Sale$13.552643,57768,376Oct 01, 2012, 04:41 PM
Halstead MichaelSenior V.P., Corp. DevelopmentOct 01, 2012 Sale$13.55771,04340,708Oct 01, 2012, 04:40 PM
BAIN CAPITAL INVESTORS LLC10% OwnerSep 11, 2012 Sale$13.1012,890,449168,864,88711,491,622Sep 13, 2012, 05:29 PM
CONNAUGHTON JOHNDirectorSep 11, 2012 Sale$13.1012,890,449168,864,88711,491,622Sep 13, 2012, 05:29 PM
THL WC (Dutch) B.V.10% OwnerSep 11, 2012 Sale$13.1014,000,000183,400,00511,491,622Sep 13, 2012, 04:54 PM
ABBRECHT TODD MDirectorSep 11, 2012 Sale$13.1014,000,000183,400,00511,491,622Sep 13, 2012, 04:53 PM
Hara IzumiSenior V.P.Sep 11, 2012 Sale$13.10126,9931,663,60873,885Sep 12, 2012, 04:11 PM
Herendeen PaulExec. V.P. and CFOSep 11, 2012 Sale$13.10309,2404,051,044110,896Sep 12, 2012, 04:10 PM
Howard Alvin DSr. V.P., Regulatory AffairsSep 11, 2012 Sale$13.10147,6391,934,07189,537Sep 12, 2012, 04:08 PM
Ellman HermanSenior V.P., Clinical Devel.Sep 11, 2012 Sale$13.1023,500307,850170,872Sep 12, 2012, 04:07 PM
Murray Stephen PDirectorSep 11, 2012 Sale$13.1014,000,000183,400,00511,491,618Sep 12, 2012, 10:26 AM
JPMP MASTER FUND MANAGER L P10% OwnerSep 11, 2012 Sale$13.1028,762,425376,787,77811,491,618Sep 11, 2012, 03:45 PM
JP MORGAN PARTNERS BHCA LP10% OwnerSep 11, 2012 Sale$13.1028,762,425376,787,77811,491,618Sep 11, 2012, 03:03 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJul 02, 2012 Sale$17.963556,37640,785Jul 02, 2012, 04:30 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Apr 02, 2012 Sale$16.9570311,916148,240Apr 03, 2012, 04:03 PM
Cross Leland HSenior V.P., Tech. OperationsMar 01, 2012 Sale$17.005589,486193,345Mar 02, 2012, 04:25 PM
Fenton AndrewSenior V.P., CIOMar 01, 2012 Sale$17.003866,56296,617Mar 02, 2012, 04:23 PM
Gilligan Claire ASenior V.P., QualityMar 01, 2012 Sale$17.0097316,54068,640Mar 02, 2012, 04:20 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Mar 01, 2012 Sale$17.0071012,069200,878Mar 02, 2012, 04:18 PM
Howard Alvin DSr. V.P., Regulatory AffairsMar 01, 2012 Sale$17.0071012,069237,176Mar 02, 2012, 04:16 PM
Fuhrmann RochelleSenior V.P., FinanceMar 01, 2012 Sale$17.0071012,06945,339Mar 02, 2012, 04:13 PM
Halstead MichaelSenior V.P., Corp. DevelopmentMar 01, 2012 Sale$17.0072512,32441,140Mar 02, 2012, 04:12 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Mar 01, 2012 Sale$17.002,48542,243148,943Mar 02, 2012, 04:08 PM
Herendeen PaulExec. V.P. and CFOMar 01, 2012 Sale$17.001,82731,058420,136Mar 02, 2012, 03:59 PM
Boissonneault Roger MCEO & PresidentMar 01, 2012 Sale$17.005,32090,4362,253,675Mar 02, 2012, 03:58 PM
Fenton AndrewSenior V.P., CIOFeb 21, 2012 Sale$16.824096,88097,003Feb 23, 2012, 04:36 PM
Gilligan Claire ASenior V.P., QualityFeb 21, 2012 Sale$16.821,03017,32769,613Feb 23, 2012, 04:34 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Feb 21, 2012 Sale$16.8275212,651201,588Feb 23, 2012, 04:28 PM
Howard Alvin DSr. V.P., Regulatory AffairsFeb 21, 2012 Sale$16.8275212,651237,886Feb 23, 2012, 04:24 PM
Cross Leland HSenior V.P., Tech. OperationsFeb 21, 2012 Sale$16.825909,925193,903Feb 23, 2012, 04:22 PM
Fuhrmann RochelleSenior V.P., FinanceFeb 21, 2012 Sale$16.8275212,65146,049Feb 23, 2012, 04:20 PM
Ellman HermanSenior V.P., Clinical Devel.Feb 21, 2012 Sale$16.8267711,389194,372Feb 23, 2012, 04:17 PM
Halstead MichaelSenior V.P., Corp. DevelopmentFeb 21, 2012 Sale$16.824096,88041,865Feb 23, 2012, 04:14 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Feb 21, 2012 Sale$16.822,56143,082146,458Feb 23, 2012, 04:08 PM
Herendeen PaulExec. V.P. and CFOFeb 21, 2012 Sale$16.821,93332,518421,963Feb 23, 2012, 04:08 PM
Boissonneault Roger MCEO & PresidentFeb 21, 2012 Sale$16.825,62894,6772,258,995Feb 23, 2012, 04:07 PM
Fenton AndrewSenior V.P., CIOJan 30, 2012 Sale$16.453515,77576,622Jan 31, 2012, 05:41 PM
Gilligan Claire ASenior V.P., QualityJan 30, 2012 Sale$16.454807,89749,853Jan 31, 2012, 05:39 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Jan 30, 2012 Sale$16.4563510,447181,550Jan 31, 2012, 05:36 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 30, 2012 Sale$16.455799,526217,848Jan 31, 2012, 05:33 PM
Cross Leland HSenior V.P., Tech. OperationsJan 30, 2012 Sale$16.455048,292173,703Jan 31, 2012, 05:31 PM
Fuhrmann RochelleSenior V.P., FinanceJan 30, 2012 Sale$16.452814,62326,011Jan 31, 2012, 05:28 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 30, 2012 Sale$16.455799,526174,259Jan 31, 2012, 05:25 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 30, 2012 Sale$16.453205,26521,484Jan 31, 2012, 05:23 PM
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.Jan 30, 2012 Sale$16.452,21536,44138,699Jan 31, 2012, 05:21 PM
Herendeen PaulExec. V.P. and CFOJan 30, 2012 Sale$16.452,18735,980365,376Jan 31, 2012, 05:04 PM
Boissonneault Roger MCEO & PresidentJan 30, 2012 Sale$16.458,317136,8292,095,663Jan 31, 2012, 05:01 PM
Fenton AndrewSenior V.P., CIOJan 23, 2012 Sale$17.3262110,75576,973Jan 24, 2012, 05:00 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Jan 23, 2012 Sale$17.321,16920,246182,185Jan 24, 2012, 04:57 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 23, 2012 Sale$17.321,22521,216218,427Jan 24, 2012, 04:54 PM
Gilligan Claire ASenior V.P., QualityJan 23, 2012 Sale$17.3293316,15950,333Jan 24, 2012, 04:51 PM
Fuhrmann RochelleSenior V.P., FinanceJan 23, 2012 Sale$17.324878,43526,292Jan 24, 2012, 04:49 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 23, 2012 Sale$17.321,16920,246174,838Jan 24, 2012, 04:47 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 23, 2012 Sale$17.324878,43521,804Jan 24, 2012, 04:46 PM
Cross Leland HSenior V.P., Tech. OperationsJan 23, 2012 Sale$17.3292115,951174,207Jan 24, 2012, 04:44 PM
Herendeen PaulExec. V.P. and CFOJan 23, 2012 Sale$17.324,14971,859367,563Jan 24, 2012, 04:41 PM
Boissonneault Roger MCEO & PresidentJan 23, 2012 Sale$17.3213,652236,4462,103,980Jan 24, 2012, 04:36 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 11, 2012 Sale$16.661,14619,093219,652Jan 12, 2012, 04:22 PM
Fuhrmann RochelleSenior V.P., FinanceJan 11, 2012 Sale$16.664116,84726,779Jan 12, 2012, 04:18 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 11, 2012 Sale$16.661,04217,360176,007Jan 12, 2012, 04:16 PM
Halstead MichaelSenior V.P., Corp. DevelopmentJan 11, 2012 Sale$16.664527,53122,291Jan 12, 2012, 04:14 PM
Fenton AndrewSenior V.P., CIOJan 11, 2012 Sale$16.665589,29777,594Jan 12, 2012, 04:12 PM
Gilligan Claire ASenior V.P., QualityJan 11, 2012 Sale$16.6683913,97851,266Jan 12, 2012, 04:09 PM
Cross Leland HSenior V.P., Tech. OperationsJan 11, 2012 Sale$16.6690815,128175,128Jan 12, 2012, 04:07 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Jan 11, 2012 Sale$16.661,09518,243183,354Jan 12, 2012, 04:03 PM
Fawzi Mahdi BPresident, Research & Develop.Oct 21, 2011 Sale$16.802,41840,62357,755Oct 24, 2011, 04:23 PM
Gilligan Claire ASenior V.P., QualityOct 03, 2011 Sale$14.032703,78852,105Oct 03, 2011, 04:06 PM
Halstead MichaelSenior V.P., Corp. DevelopmentOct 03, 2011 Sale$14.03781,09422,743Oct 03, 2011, 04:06 PM
Cross Leland HSenior V.P., Tech. OperationsJun 10, 2011 Sale$22.2979,5631,773,746176,036Jun 13, 2011, 04:39 PM
Cross Leland HSenior V.P., Tech. OperationsJun 09, 2011 Sale$22.41100,0002,241,010255,599Jun 13, 2011, 04:39 PM
van Zoonen Marinus JohannesPres., Europe/Int'l&Glob. Mkt.Apr 01, 2011 Sale$23.3070316,38040,914Apr 04, 2011, 04:13 PM
CONNAUGHTON JOHNDirectorMar 30, 2011 Sale$22.44466,19610,459,71325,491,622Apr 01, 2011, 05:23 PM
BAIN CAPITAL INVESTORS LLC10% OwnerMar 30, 2011 Sale$22.44466,19610,459,71325,491,622Apr 01, 2011, 05:23 PM
THL WC (Dutch) B.V.10% OwnerMar 30, 2011 Sale$22.44466,19410,461,39425,491,622Apr 01, 2011, 12:17 PM
BAIN CAPITAL INVESTORS LLC10% OwnerMar 30, 2011 Sale$22.44446,19610,010,98725,511,622Apr 01, 2011, 12:02 PM
CONNAUGHTON JOHNDirectorMar 30, 2011 Sale$22.44446,19610,010,98725,511,622Apr 01, 2011, 12:01 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Mar 30, 2011 Sale$23.253,71386,327184,449Mar 31, 2011, 04:20 PM
Gilligan Claire ASenior V.P. Global QualityMar 30, 2011 Sale$23.2551211,90428,049Mar 31, 2011, 04:20 PM
Gilligan Claire ASenior V.P. Global QualityMar 30, 2011 Sale$23.251,03123,97152,375Mar 31, 2011, 04:20 PM
Ellman HermanSenior V.P., Clinical Devel.Mar 30, 2011 Sale$23.253,54682,445177,049Mar 31, 2011, 04:19 PM
Herendeen PaulExec. V.P. and CFOMar 30, 2011 Sale$23.2515,406358,190371,712Mar 31, 2011, 04:19 PM
Reichel Carl WPresident, PharmaceuticalsMar 30, 2011 Sale$23.2518,020418,965371,594Mar 31, 2011, 04:18 PM
Bruno Anthony DExec. V.P., Corp. DevelopmentMar 30, 2011 Sale$23.2516,848391,716308,123Mar 31, 2011, 04:17 PM
JPMP MASTER FUND MANAGER L P10% OwnerMar 30, 2011 Sale$22.44932,38920,919,36025,491,618Mar 30, 2011, 05:35 PM
JP MORGAN PARTNERS BHCA LP10% OwnerMar 30, 2011 Sale$22.44932,38920,919,36025,491,618Mar 30, 2011, 05:34 PM
Murray Stephen PDirectorMar 30, 2011 Sale$22.44466,19410,459,66925,491,618Mar 30, 2011, 05:31 PM
CONNAUGHTON JOHNDirectorMar 16, 2011 Sale$22.446,919,748155,253,54425,957,818Mar 18, 2011, 05:51 PM
BAIN CAPITAL INVESTORS LLC10% OwnerMar 16, 2011 Sale$22.446,919,748155,253,54425,957,818Mar 18, 2011, 05:28 PM
JPMP MASTER FUND MANAGER L P10% OwnerMar 16, 2011 Sale$22.4415,722,194352,747,86625,957,812Mar 18, 2011, 03:42 PM
JP MORGAN PARTNERS BHCA LP10% OwnerMar 16, 2011 Sale$22.4415,722,194352,747,86625,957,812Mar 18, 2011, 03:40 PM
THL WC (Dutch) B.V.10% OwnerMar 16, 2011 Sale$23.257,861,448182,778,66625,957,816Mar 18, 2011, 02:25 PM
MURRAY STEPHENDirectorMar 16, 2011 Sale$22.447,861,447176,381,78625,957,812Mar 18, 2011, 02:05 PM
Hara IzumiSr. VP, Gen. Counsel & Sec.Mar 16, 2011 Sale$23.2563,5311,477,096188,162Mar 17, 2011, 04:02 PM
Gilligan Claire ASenior V.P. Global QualityMar 16, 2011 Sale$23.2517,637410,06053,406Mar 17, 2011, 04:02 PM
Gilligan Claire ASenior V.P. Global QualityMar 16, 2011 Sale$23.258,774203,99628,561Mar 17, 2011, 04:02 PM
Ellman HermanSenior V.P., Clinical Devel.Mar 16, 2011 Sale$23.2560,6681,410,531180,595Mar 17, 2011, 04:02 PM
Bruno Anthony DExec. V.P., Corp. DevelopmentMar 16, 2011 Sale$23.25400,0009,300,000324,971Mar 17, 2011, 04:02 PM
Herendeen PaulExec. V.P. and CFOMar 16, 2011 Sale$23.25400,0009,300,000387,118Mar 17, 2011, 04:01 PM
Reichel Carl WPresident, PharmaceuticalsMar 16, 2011 Sale$23.25400,0009,300,000389,614Mar 17, 2011, 04:01 PM
Fuhrmann RochelleSenior V.P., Global FinanceJan 31, 2011 Sale$23.352786,49111,510Feb 01, 2011, 04:18 PM
Gilligan Claire ASenior V.P. Global QualityJan 31, 2011 Sale$23.3547411,06855,363Feb 01, 2011, 04:17 PM
van Zoonen Marinus JohannesPres., Europe/Int'l&Glob. Mkt.Jan 31, 2011 Sale$23.352,21551,71921,127Feb 01, 2011, 04:17 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 31, 2011 Sale$23.3557213,356227,153Feb 01, 2011, 04:16 PM
Cross Leland HSenior V.P., Tech. OperationsJan 31, 2011 Sale$23.3557213,356341,489Feb 01, 2011, 04:15 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 31, 2011 Sale$23.3557213,356205,118Feb 01, 2011, 04:15 PM
Herendeen PaulExec. V.P. and CFOJan 31, 2011 Sale$23.352,15250,248746,748Feb 01, 2011, 04:14 PM
Bruno Anthony DExec. V.P., Corp. DevelopmentJan 31, 2011 Sale$23.352,15250,248684,601Feb 01, 2011, 04:14 PM
Reichel Carl WPresident, PharmaceuticalsJan 31, 2011 Sale$23.352,15250,248749,244Feb 01, 2011, 04:13 PM
Boissonneault Roger MCEO & PresidentJan 31, 2011 Sale$23.358,228192,1202,000,062Feb 01, 2011, 04:12 PM
Cross Leland HSenior V.P., Tech. OperationsJan 21, 2011 Sale$23.621,05424,898342,061Jan 24, 2011, 06:03 PM
Fuhrmann RochelleSenior V.P., Global FinanceJan 21, 2011 Sale$23.6248511,45711,788Jan 24, 2011, 06:01 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 21, 2011 Sale$23.621,16427,496227,725Jan 24, 2011, 06:01 PM
Gilligan Claire ASenior V.P. Global QualityJan 21, 2011 Sale$23.6292921,94555,837Jan 24, 2011, 06:00 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 21, 2011 Sale$23.621,21928,795205,690Jan 24, 2011, 05:58 PM
Reichel Carl WPresident, PharmaceuticalsJan 21, 2011 Sale$23.624,09696,757751,396Jan 24, 2011, 05:56 PM
Herendeen PaulExec. V.P. and CFOJan 21, 2011 Sale$23.624,09696,757748,900Jan 24, 2011, 05:55 PM
Bruno Anthony DExec. V.P., Corp. DevelopmentJan 21, 2011 Sale$23.624,09796,780686,753Jan 24, 2011, 05:54 PM
Boissonneault Roger MCEO & PresidentJan 21, 2011 Sale$23.6213,580320,7892,008,290Jan 24, 2011, 05:48 PM
Cross Leland HSenior V.P., Tech. OperationsJan 11, 2011 Sale$23.851,03024,566343,115Jan 11, 2011, 06:46 PM
Howard Alvin DSr. V.P., Regulatory AffairsJan 11, 2011 Sale$23.851,13327,022206,909Jan 11, 2011, 06:46 PM
Ellman HermanSenior V.P., Clinical Devel.Jan 11, 2011 Sale$23.851,03024,566228,889Jan 11, 2011, 06:45 PM
Gilligan Claire ASenior V.P. Global QualityJan 11, 2011 Sale$23.8582919,77256,766Jan 11, 2011, 06:45 PM
AlpInvest Partners CS Investments 2003 C.V.10% OwnerSep 22, 2010 Sale$22.92481,24011,030,0212,693,910Nov 01, 2010, 03:38 PM
AlpInvest Partners CS Investments 2003 C.V.10% OwnerSep 27, 2010 Sale$22.68651,02814,765,3150Nov 01, 2010, 03:38 PM
AlpInvest Partners CS Investments 2003 C.V.10% OwnerSep 24, 2010 Sale$22.781,649,64537,578,914651,028Nov 01, 2010, 03:38 PM
AlpInvest Partners CS Investments 2003 C.V.10% OwnerSep 23, 2010 Sale$22.85393,2378,985,4662,300,673Nov 01, 2010, 03:38 PM
Fawzi Mahdi BPresident, Research & Develop.Oct 21, 2010 Sale$24.202,46759,70123,833Oct 21, 2010, 05:41 PM
CREDIT SUISSE AG/10% OwnerSep 30, 2010 Sale$21.4815,000,000322,199,99310,225,584Oct 04, 2010, 11:00 AM
CREDIT SUISSE AG/10% OwnerSep 29, 2010 Sale$22.50322,7977,263,19025,225,584Oct 01, 2010, 02:31 PM
CREDIT SUISSE AG/10% OwnerSep 28, 2010 Sale$22.53575,00012,955,44025,548,651Sep 30, 2010, 03:45 PM
Gilligan Claire ASenior V.P. Global QualitySep 22, 2010 Sale$23.0595622,03455,555Sep 22, 2010, 04:57 PM
Cross Leland HSenior V.P., Tech. OperationsSep 22, 2010 Sale$23.051,17126,990344,145Sep 22, 2010, 04:56 PM
Howard Alvin DSr. V.P., Regulatory AffairsSep 22, 2010 Sale$23.051,42232,775208,042Sep 22, 2010, 04:56 PM
Ellman HermanSenior V.P., Clinical Devel.Sep 22, 2010 Sale$23.051,17126,990229,919Sep 22, 2010, 04:55 PM
CREDIT SUISSE AG/10% OwnerSep 14, 2010 Sale$22.01124,7172,745,38326,123,651Sep 16, 2010, 03:24 PM
CREDIT SUISSE AG/10% OwnerSep 13, 2010 Sale$22.0538,712853,67326,248,368Sep 14, 2010, 04:31 PM
CREDIT SUISSE AG/10% OwnerSep 10, 2010 Sale$22.03109,8002,419,10326,287,080Sep 14, 2010, 04:31 PM
BLOEM JAMES HDirectorAug 13, 2010 Option Exercise$16.2319,176311,30824,176Aug 17, 2010, 11:50 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Halstead MichaelSenior V.P., Corp. Development07/01/20137,276
Sullivan Ryan TVP, General Counsel & Secr.07/01/20133,360
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.04/01/20139,428
CONNAUGHTON JOHNDirector03/04/2013142,655,493
Ellman HermanSenior V.P., Clinical Devel.03/01/201322,293
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.02/28/2013213,655
Rodriguez Rama FranciscoSenior V.P., Tech. Operations02/28/201311,040
Gilligan Claire ASenior V.P., Quality02/28/201331,694
Cross Leland HSenior V.P., Tech. Operations02/28/201317,826
Fenton AndrewSenior V.P., CIO02/28/201318,715
Howard Alvin DSr. V.P., Regulatory Affairs02/28/201323,265
Halstead MichaelSenior V.P., Corp. Development02/28/201323,521
Fuhrmann RochelleSenior V.P., Finance02/28/201323,265
Herendeen PaulExec. V.P. and CFO02/28/201362,929
Boissonneault Roger MCEO & President02/28/2013252,175
Fenton AndrewSenior V.P., CIO02/19/20136,087
Ellman HermanSenior V.P., Clinical Devel.02/19/201310,039
Gilligan Claire ASenior V.P., Quality02/19/201315,181
Cross Leland HSenior V.P., Tech. Operations02/19/20138,034
Howard Alvin DSr. V.P., Regulatory Affairs02/19/201311,143
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.02/19/201337,220
Fuhrmann RochelleSenior V.P., Finance02/19/201311,143
Halstead MichaelSenior V.P., Corp. Development02/19/20136,087
Herendeen PaulExec. V.P. and CFO02/19/201328,605
Boissonneault Roger MCEO & President02/19/2013115,176
Fenton AndrewSenior V.P., CIO02/01/201314,121
Cross Leland HSenior V.P., Tech. Operations02/01/201311,456
Ellman HermanSenior V.P., Clinical Devel.02/01/201314,320
Halstead MichaelSenior V.P., Corp. Development02/01/201314,150
Howard Alvin DSr. V.P., Regulatory Affairs02/01/201314,320
Gilligan Claire ASenior V.P., Quality02/01/201319,523
Fuhrmann RochelleSenior V.P., Finance02/01/201314,150
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.02/01/2013195,517
Herendeen PaulExec. V.P. and CFO02/01/201340,266
Boissonneault Roger MCEO & President02/01/2013129,376
Cross Leland HSenior V.P., Tech. Operations01/30/20136,224
Gilligan Claire ASenior V.P., Quality01/30/20136,545
Fenton AndrewSenior V.P., CIO01/30/20134,698
Ellman HermanSenior V.P., Clinical Devel.01/30/20137,843
Howard Alvin DSr. V.P., Regulatory Affairs01/30/20137,910
Fuhrmann RochelleSenior V.P., Finance01/30/20133,774
Halstead MichaelSenior V.P., Corp. Development01/30/20134,283
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.01/30/201331,621
Herendeen PaulExec. V.P. and CFO01/30/201329,552
Boissonneault Roger MCEO & President01/30/2013113,363
Fenton AndrewSenior V.P., CIO01/22/20138,383
Ellman HermanSenior V.P., Clinical Devel.01/22/201315,741
Gilligan Claire ASenior V.P., Quality01/22/201312,811
Howard Alvin DSr. V.P., Regulatory Affairs01/22/201316,497
Cross Leland HSenior V.P., Tech. Operations01/22/201311,326
Fuhrmann RochelleSenior V.P., Finance01/22/20136,588
Halstead MichaelSenior V.P., Corp. Development01/22/20136,588
Herendeen PaulExec. V.P. and CFO01/22/201358,117
Boissonneault Roger MCEO & President01/22/2013187,973
Murray Stephen PDirector11/28/201274,069,360
Murray Stephen PDirector11/20/201258,299,999
Gilligan Claire ASenior V.P., Quality10/01/20123,577
Halstead MichaelSenior V.P., Corp. Development10/01/20121,043
BAIN CAPITAL INVESTORS LLC10% Owner09/11/2012168,864,887
CONNAUGHTON JOHNDirector09/11/2012168,864,887
THL WC (Dutch) B.V.10% Owner09/11/2012183,400,005
ABBRECHT TODD MDirector09/11/2012183,400,005
Hara IzumiSenior V.P.09/11/20121,663,608
Herendeen PaulExec. V.P. and CFO09/11/20124,051,044
Howard Alvin DSr. V.P., Regulatory Affairs09/11/20121,934,071
Ellman HermanSenior V.P., Clinical Devel.09/11/2012307,850
Murray Stephen PDirector09/11/2012183,400,005
JPMP MASTER FUND MANAGER L P10% Owner09/11/2012376,787,778
JP MORGAN PARTNERS BHCA LP10% Owner09/11/2012376,787,778
Halstead MichaelSenior V.P., Corp. Development07/02/20126,376
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.04/02/201211,916
Cross Leland HSenior V.P., Tech. Operations03/01/20129,486
Fenton AndrewSenior V.P., CIO03/01/20126,562
Gilligan Claire ASenior V.P., Quality03/01/201216,540
Hara IzumiSr. VP, Gen. Counsel & Sec.03/01/201212,069
Howard Alvin DSr. V.P., Regulatory Affairs03/01/201212,069
Fuhrmann RochelleSenior V.P., Finance03/01/201212,069
Halstead MichaelSenior V.P., Corp. Development03/01/201212,324
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.03/01/201242,243
Herendeen PaulExec. V.P. and CFO03/01/201231,058
Boissonneault Roger MCEO & President03/01/201290,436
Fenton AndrewSenior V.P., CIO02/21/20126,880
Gilligan Claire ASenior V.P., Quality02/21/201217,327
Hara IzumiSr. VP, Gen. Counsel & Sec.02/21/201212,651
Howard Alvin DSr. V.P., Regulatory Affairs02/21/201212,651
Cross Leland HSenior V.P., Tech. Operations02/21/20129,925
Fuhrmann RochelleSenior V.P., Finance02/21/201212,651
Ellman HermanSenior V.P., Clinical Devel.02/21/201211,389
Halstead MichaelSenior V.P., Corp. Development02/21/20126,880
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.02/21/201243,082
Herendeen PaulExec. V.P. and CFO02/21/201232,518
Boissonneault Roger MCEO & President02/21/201294,677
Fenton AndrewSenior V.P., CIO01/30/20125,775
Gilligan Claire ASenior V.P., Quality01/30/20127,897
Hara IzumiSr. VP, Gen. Counsel & Sec.01/30/201210,447
Howard Alvin DSr. V.P., Regulatory Affairs01/30/20129,526
Cross Leland HSenior V.P., Tech. Operations01/30/20128,292
Fuhrmann RochelleSenior V.P., Finance01/30/20124,623
Ellman HermanSenior V.P., Clinical Devel.01/30/20129,526
Halstead MichaelSenior V.P., Corp. Development01/30/20125,265
van Zoonen Marinus JohannesPresident, Europe/Int'l & Mkt.01/30/201236,441
Herendeen PaulExec. V.P. and CFO01/30/201235,980
Boissonneault Roger MCEO & President01/30/2012136,829
Fenton AndrewSenior V.P., CIO01/23/201210,755
Hara IzumiSr. VP, Gen. Counsel & Sec.01/23/201220,246
Howard Alvin DSr. V.P., Regulatory Affairs01/23/201221,216
Gilligan Claire ASenior V.P., Quality01/23/201216,159
Fuhrmann RochelleSenior V.P., Finance01/23/20128,435
Ellman HermanSenior V.P., Clinical Devel.01/23/201220,246
Halstead MichaelSenior V.P., Corp. Development01/23/20128,435
Cross Leland HSenior V.P., Tech. Operations01/23/201215,951
Herendeen PaulExec. V.P. and CFO01/23/201271,859
Boissonneault Roger MCEO & President01/23/2012236,446
Howard Alvin DSr. V.P., Regulatory Affairs01/11/201219,093
Fuhrmann RochelleSenior V.P., Finance01/11/20126,847
Ellman HermanSenior V.P., Clinical Devel.01/11/201217,360
Halstead MichaelSenior V.P., Corp. Development01/11/20127,531
Fenton AndrewSenior V.P., CIO01/11/20129,297
Gilligan Claire ASenior V.P., Quality01/11/201213,978
Cross Leland HSenior V.P., Tech. Operations01/11/201215,128
Hara IzumiSr. VP, Gen. Counsel & Sec.01/11/201218,243
Fawzi Mahdi BPresident, Research & Develop.10/21/201140,623
Gilligan Claire ASenior V.P., Quality10/03/20113,788
Halstead MichaelSenior V.P., Corp. Development10/03/20111,094
Cross Leland HSenior V.P., Tech. Operations06/10/20111,773,746
Cross Leland HSenior V.P., Tech. Operations06/09/20112,241,010
van Zoonen Marinus JohannesPres., Europe/Int'l&Glob. Mkt.04/01/201116,380
CONNAUGHTON JOHNDirector03/30/201110,459,713
BAIN CAPITAL INVESTORS LLC10% Owner03/30/201110,459,713
THL WC (Dutch) B.V.10% Owner03/30/201110,461,394
BAIN CAPITAL INVESTORS LLC10% Owner03/30/201110,010,987
CONNAUGHTON JOHNDirector03/30/201110,010,987
Hara IzumiSr. VP, Gen. Counsel & Sec.03/30/201186,327
Gilligan Claire ASenior V.P. Global Quality03/30/201111,904
Gilligan Claire ASenior V.P. Global Quality03/30/201123,971
Ellman HermanSenior V.P., Clinical Devel.03/30/201182,445
Herendeen PaulExec. V.P. and CFO03/30/2011358,190
Reichel Carl WPresident, Pharmaceuticals03/30/2011418,965
Bruno Anthony DExec. V.P., Corp. Development03/30/2011391,716
JPMP MASTER FUND MANAGER L P10% Owner03/30/201120,919,360
JP MORGAN PARTNERS BHCA LP10% Owner03/30/201120,919,360
Murray Stephen PDirector03/30/201110,459,669
CONNAUGHTON JOHNDirector03/16/2011155,253,544
BAIN CAPITAL INVESTORS LLC10% Owner03/16/2011155,253,544
JPMP MASTER FUND MANAGER L P10% Owner03/16/2011352,747,866
JP MORGAN PARTNERS BHCA LP10% Owner03/16/2011352,747,866
THL WC (Dutch) B.V.10% Owner03/16/2011182,778,666
MURRAY STEPHENDirector03/16/2011176,381,786
Hara IzumiSr. VP, Gen. Counsel & Sec.03/16/20111,477,096
Gilligan Claire ASenior V.P. Global Quality03/16/2011410,060
Gilligan Claire ASenior V.P. Global Quality03/16/2011203,996
Ellman HermanSenior V.P., Clinical Devel.03/16/20111,410,531
Bruno Anthony DExec. V.P., Corp. Development03/16/20119,300,000
Herendeen PaulExec. V.P. and CFO03/16/20119,300,000
Reichel Carl WPresident, Pharmaceuticals03/16/20119,300,000
Fuhrmann RochelleSenior V.P., Global Finance01/31/20116,491
Gilligan Claire ASenior V.P. Global Quality01/31/201111,068
van Zoonen Marinus JohannesPres., Europe/Int'l&Glob. Mkt.01/31/201151,719
Ellman HermanSenior V.P., Clinical Devel.01/31/201113,356
Cross Leland HSenior V.P., Tech. Operations01/31/201113,356
Howard Alvin DSr. V.P., Regulatory Affairs01/31/201113,356
Herendeen PaulExec. V.P. and CFO01/31/201150,248
Bruno Anthony DExec. V.P., Corp. Development01/31/201150,248
Reichel Carl WPresident, Pharmaceuticals01/31/201150,248
Boissonneault Roger MCEO & President01/31/2011192,120
Cross Leland HSenior V.P., Tech. Operations01/21/201124,898
Fuhrmann RochelleSenior V.P., Global Finance01/21/201111,457
Ellman HermanSenior V.P., Clinical Devel.01/21/201127,496
Gilligan Claire ASenior V.P. Global Quality01/21/201121,945
Howard Alvin DSr. V.P., Regulatory Affairs01/21/201128,795
Reichel Carl WPresident, Pharmaceuticals01/21/201196,757
Herendeen PaulExec. V.P. and CFO01/21/201196,757
Bruno Anthony DExec. V.P., Corp. Development01/21/201196,780
Boissonneault Roger MCEO & President01/21/2011320,789
Cross Leland HSenior V.P., Tech. Operations01/11/201124,566
Howard Alvin DSr. V.P., Regulatory Affairs01/11/201127,022
Ellman HermanSenior V.P., Clinical Devel.01/11/201124,566
Gilligan Claire ASenior V.P. Global Quality01/11/201119,772
AlpInvest Partners CS Investments 2003 C.V.10% Owner09/22/201011,030,021
AlpInvest Partners CS Investments 2003 C.V.10% Owner09/27/201014,765,315
AlpInvest Partners CS Investments 2003 C.V.10% Owner09/24/201037,578,914
AlpInvest Partners CS Investments 2003 C.V.10% Owner09/23/20108,985,466
Fawzi Mahdi BPresident, Research & Develop.10/21/201059,701
CREDIT SUISSE AG/10% Owner09/30/2010322,199,993
CREDIT SUISSE AG/10% Owner09/29/20107,263,190
CREDIT SUISSE AG/10% Owner09/28/201012,955,440
Gilligan Claire ASenior V.P. Global Quality09/22/201022,034
Cross Leland HSenior V.P., Tech. Operations09/22/201026,990
Howard Alvin DSr. V.P., Regulatory Affairs09/22/201032,775
Ellman HermanSenior V.P., Clinical Devel.09/22/201026,990
CREDIT SUISSE AG/10% Owner09/14/20102,745,383
CREDIT SUISSE AG/10% Owner09/13/2010853,673
CREDIT SUISSE AG/10% Owner09/10/20102,419,103
BLOEM JAMES HDirector08/13/2010311,308
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...